Pre-Open Stock Movers 07/13: (BFYT) (ALT) (TSLA) Higher; (CLSN) Lower (more...)
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- ICZOOM Group (IZM) Discloses Request to Withdraw Registration Statement on Form F-1
- Alaska Airlines flights resume after being grounded over aircraft system issue
- Crude Inventory Rose 2.7 Million Barrels Last Week, Says EIA
- Lithium Americas Corp (LAC) Announces Proposed 55M Share Offering
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
- After-hours movers: United Airlines, J.B. Hunt, and more
- Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
- Morgan Stanley, UnitedHealth and Bank of America rise premarket; Tesla falls
Guggenheim Reiterates Buy Rating on Pepsico (PEP) Following Investor Call
July 15, 2020 7:56 AM EDTGuggenheim analyst Laurent Grandet reiterated a Buy rating and $151.00 price target on Pepsico (NASDAQ: PEP) following an investor call with management. Grandet thinks CEO Laguarta is taking aggressive steps to reposition the beverage business and capture market share that Grandet expects will provide strong,... More
Altimmune (ALT) Prices 3.37M Share Common Offering at $23/Sh
July 14, 2020 5:45 AM EDTAltimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, today announced the pricing of its previously announced underwritten public offering of 3,369,564 shares of its common stock and, to certain investors in lieu thereof, pre-funded warrants to purchase 1,630,436 shares of its common stock at an exercise price of $0.0001 per share. The public offering price of each share of common stock is $23.00 and the public offering price of each pre-funded warrant is $22.999 per underlying share. In addition, Altimmune has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of its common stock at the... More